
Sunfish, a fertility financing provider, has secured $10 million in Series A funding led by Haymaker Ventures, with participation from Allegis Capital and Mother Ventures, as reported by Axios. Existing investors Walkabout Ventures, Hannah Grey VC, Fiat Ventures, and Coyote Ventures also joined the round.
The company aims to address the significant financial burden of fertility treatments through a membership model that combines financial tools, predictive modeling, and virtual care support. As founder and CEO Angela Rastegar told Axios, the fundraising process was notably smoother than their 2022 seed round, completed in “six weeks” compared to earlier efforts that required “a lot of explaining to the VC community of what IVF was, what the process was [and] why it was important.”
Sunfish’s IVF Success Program uses patient biodata to create personalized treatment cost estimates and offers partial refunds if treatments are unsuccessful or if cost predictions prove inaccurate. The program is currently available in 14 U.S. fertility clinic locations, while their lending service reaches nearly 100 locations.
The solution comes at a critical time, with fertility treatments in the U.S. averaging $15,000 to $25,000 per cycle and success rates ranging from 25% to 40%. The company currently focuses on patients without insurance coverage but plans to expand to those with partial coverage.
Despite recent political uncertainty around reproductive healthcare, Rastegar told Axios that investor interest remains strong, noting that “in general, there’s bipartisan support for covering family building.”